cdmo.directory
← Compare landing

Omniabio vs Synthego

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryOmniabioSynthego
SummaryOmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.Synthego manufactures GMP-grade CRISPR components and molecular biology reagents for clinical and research applications, with 19 INDs cleared and 200+ clinical sgRNA batches produced.
Services
  • Cell-Line Development
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • Cell Therapy
  • Gene Therapy
Development capabilities
  • Analytical method development
  • Cell line development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Drug Substance (DS)
  • Expression: Cell-Free
Locations
  • Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Omniabio alternatives · Synthego alternatives

Markdown mirror: /compare/omniabio/synthego.md